Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Anti-Tumor Activities of Probiotics in Cervical Cancer Publisher Pubmed



Jahanshahi M1 ; Maleki Dana P2 ; Badehnoosh B3 ; Asemi Z2 ; Hallajzadeh J4 ; Mansournia MA5 ; Yousefi B6, 7 ; Moazzami B8 ; Chaichian S8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Clinical Research Development Center (CRDC), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran
  2. 2. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
  3. 3. Department of Gynecology and Obstetrics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
  4. 4. Department of Biochemistry and Nutrition, Research Center for Evidence-Based Health Management, Maragheh University of Medical Sciences, Maragheh, Iran
  5. 5. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  7. 7. Department of Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  8. 8. Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran

Source: Journal of Ovarian Research Published:2020


Abstract

Cervical cancer is considered as an important malignancy among women worldwide. Currently-used treatments of cervical cancer are reported to be cytotoxic for patients. Moreover, these therapies have shown some side effects which can negatively affect the lives of women suffering from this cancer. Therefore, there is need for anti-tumor agents that are less toxic than common therapeutic drugs. Besides, applying agents for preventing or reducing the side effects of cervical cancer therapies can be effective in improving the life quality of cervical cancer patients. Studies have shown that probiotics have several effects on biological processes. One of the most prominent aspects in which probiotics play a role is in the field of cancer. There are multiple studies which have focused on the functions of probiotics in diagnosis, prevention, or treatment of cancer. Besides their direct anti-tumor activities, probiotics can be used as an additional agent for enhancing or modulating other diagnostic and therapeutic methods. Herein, the effects of probiotics on cervical cancer cells are discussed, which may be useful in the prevention and treatment of this cancer. We review the studies concerned with the roles of probiotics in modulating and reducing the gastrointestinal adverse effects caused by cervical cancer therapies. Furthermore, we cover the investigations focusing on the combination of probiotics with other drugs for diagnosis or treatment of cervical cancer. © 2020 The Author(s).
Other Related Docs
16. The Effects of Dietary Supplements in Patients With Cervical Cancer: A Comprehensive Systematic Review, European Journal of Obstetrics and Gynecology and Reproductive Biology: X (2023)
17. The Role of Cxc Chemokines and Receptors in Breast Cancer, Clinical and Experimental Medicine (2025)
27. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
28. Microrna Let-7 and Viral Infections: Focus on Mechanisms of Action, Cellular and Molecular Biology Letters (2022)
30. The Comparison of Food and Supplement As Probiotic Delivery Vehicles, Critical Reviews in Food Science and Nutrition (2016)
37. Lifetime Prevalence of Cervical Cancer Screening in 55 Low-And Middle-Income Countries, JAMA - Journal of the American Medical Association (2020)
39. Gut Microbiota and Covid-19: A Systematic Review, Health Science Reports (2023)
42. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer, International Archives of Allergy and Immunology (2022)
48. Gut Microbiota Might Act As a Potential Therapeutic Pathway in Covid-19, Current Pharmaceutical Biotechnology (2022)